Clinical Trials Directory

Trials / Completed

CompletedNCT01067898

A Study on Oral Vitamin D Megadoses

A Randomized, Double-blind, Placebo-controlled Study on Oral Vitamin D Megadoses - 100 000 or 200 000 IU Vitamin D3 Every Three Months

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
Female
Age
70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if infrequent administration of oral vitamin D megadoses is effective treatment to maintain serum 25-hydroxyvitamin D(3) above target levels of 50-75 nmol/L. The investigators hypothesize that 100 000 IU or at least 200 000 IU vitamin D3 in every three months would be effective and safe treatment to achieve the target levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin D3 (cholecalciferol)vitamin D3 (cholecalciferol) oil 20 000 IU/ml, oral dose of 200 000 IU or 100 000 IU (10ml or 5ml) every three months for one year.
OTHERolive oil10 ml (placebo group) or 5 ml (100 000 IU vitamin D3 group) oil per os every three months for one year
DIETARY_SUPPLEMENTcalcium carbonate1000 mg calcium per os every day for one year

Timeline

Start date
2010-02-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2010-02-12
Last updated
2012-03-27

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01067898. Inclusion in this directory is not an endorsement.